Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second BCG vaccination or BCG plus killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
ISRCTN11311670Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jan 1986
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bcg vaccine, killed Mycobacterium leprae vaccine and Placebo-COD Research Private Ltd in leprosy (HD) and Tuberculosis (TB) (6 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoints: Clinical leprosy occurrence, Clinical tuberculosis occurrence and 2 more. Started Jan 1986; status: completed.
02
Drugs
bcg vaccinekilled Mycobacterium leprae vaccinePlacebo-COD Research Private Ltd
03
Conditions
leprosy (HD)Tuberculosis (TB)
Beyond the preview
Go deeper on ISRCTN11311670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11311670.